Home › Funds › JGP Global Gestao de Recursos Ltda. › VRTX

JGP Global Gestao de Recursos Ltda. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

JGP Global Gestao de Recursos Ltda. reported holding 746 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$390K, representing 0.81% of its reported portfolio and ranking #13 among its reported holdings. JGP Global Gestao de Recursos Ltda. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)746 sh
Reported value held$390.02K
Portfolio Weight0.81%
First reportedQ3 2023
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How JGP Global Gestao de Recursos Ltda.'s VRTX position evolved

JGP Global Gestao de Recursos Ltda. first disclosed a stake in VRTX in Q3 2023 at 1,497 shares (US$521K). The position peaked in Q4 2023 at 1,492 shares, worth US$607K. Across 13 filings, JGP Global Gestao de Recursos Ltda. increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 746 shares valued at US$390K — an increase of 21 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2024 (shares rose 12% over the following quarter), a 40% trim in Q1 2025 (shares fell 8% over the following quarter), a 35% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.50K $520.57K New
Q4 2023 1.49K $607.08K Hold
Q1 2024 1.06K $442.25K Reduce
Q2 2024 1.05K $490.28K Reduce
Q3 2024 969 $450.66K Reduce
Q4 2024 968 $389.81K Hold
Q1 2025 583 $282.65K Reduce
Q2 2025 581 $258.66K Hold
Q3 2025 586 $229.50K Add
Q4 2025 532 $241.19K Reduce
Q1 2026 537 $239.79K Add
Q2 2026 725 $360.13K Add
Q3 2026 746 $390.02K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has JGP Global Gestao de Recursos Ltda. held VRTX?

JGP Global Gestao de Recursos Ltda. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JGP Global Gestao de Recursos Ltda.'s current position in VRTX?

As of Q3 2026, JGP Global Gestao de Recursos Ltda. holds 746 shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $390.02K, representing 0.81% of its reported portfolio and ranking #13.

Has JGP Global Gestao de Recursos Ltda. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), JGP Global Gestao de Recursos Ltda. increased its position in VRTX. The position peaked in Q4 2023 at 1.49K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.